Health Quality 5.0: What Does Co-Creation Have to Do With It?
Healthcare Quarterly · 2024
DOI: 10.12927/hcq.2024.27430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Healthcare Quarterly, 2024. Verfasst von Leslee J Thompson. Beteiligte Einrichtung: Leslee J. Thompson, is the chief executive officer at Health Standards Organization and Accreditation Canada in Ottawa, ON. She works as an executive…. Hauptthemen laut MEDLINE: Patient Participation. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
In this latest article in Leslee Thompson's Health Quality 5.0 series, she discusses the slow progress of patient engagement in healthcare over the past two decades, emphasizing the need for co-creation where patients and providers collaborate equally. It explores the challenges of overcoming traditional power dynamics and integrating patient knowledge into healthcare systems. Highlighting examples from around the world, the article identifies five success factors for global impact and stresses the importance of a holistic, inclusive approach to healthcare transformation. Co-creation is presented as essential for building resilient, high-performing health systems centred on patients' needs and experiences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Leslee J. Thompson, is the chief executive officer at Health Standards Organization and Accreditation Canada in Ottawa, ON. She works as an executive-in-residence at the Rotman School of Management in the University of…
Zitieren
APA
Thompson, L. J. (2024). Health Quality 5.0: What Does Co-Creation Have to Do With It?. Healthcare Quarterly. https://doi.org/10.12927/hcq.2024.27430
Vancouver
Thompson LJ. Health Quality 5.0: What Does Co-Creation Have to Do With It?. Healthcare Quarterly. 2024. doi:10.12927/hcq.2024.27430
BibTeX
@article{Thompson2024,
author = {Thompson, Leslee J},
title = {Health Quality 5.0: What Does Co-Creation Have to Do With It?},
journal = {Healthcare Quarterly},
year = {2024},
doi = {10.12927/hcq.2024.27430}
}
EUVIMED